Terns Pharmaceuticals, Inc. Share Price
TERNTerns Pharmaceuticals, Inc. Stock Performance
Open $39.80 | Prev. Close $38.94 | Circuit Range N/A |
Day Range $37.38 - $39.80 | Year Range $1.86 - $48.26 | Volume 1,15,066 |
Average Traded $38.41 |
Terns Pharmaceuticals, Inc. Share Price Chart
About Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Terns Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Jan-26 | $39.80 | $38.92 | +0.00% |
06-Jan-26 | $39.80 | $38.92 | -2.99% |
02-Jan-26 | $40.46 | $40.12 | -0.69% |
31-Dec-25 | $40.62 | $40.40 | -0.50% |
30-Dec-25 | $41.23 | $40.60 | -2.13% |
29-Dec-25 | $41.35 | $41.49 | -0.12% |
26-Dec-25 | $42.41 | $41.54 | -2.11% |
FAQs on Terns Pharmaceuticals, Inc. Share Price
Can I buy Terns Pharmaceuticals, Inc. shares in India?
What is the share price of Terns Pharmaceuticals, Inc.?
What is the 5 year returns of Terns Pharmaceuticals, Inc.?
What are the high & low stock price of Terns Pharmaceuticals, Inc. today?
What is the 52-week high and low of Terns Pharmaceuticals, Inc. stock?